In another report, a 26week treatment with the GLP1R/GIPR dual agonist LY3298176 (Tirzepatide, Eli Lilly), showed significant reduction in A1c in an incremental, dosedependent manner (4 doses from 1 mg to 15 mg, A1c reduction from 1.06% to 1.94% respectively)
Effects of rosmarinic acid on liver and kidney antioxidant enzymes, lipid peroxidation and tissue ultrastructure in aging mice
The interrelation between hypothyroidism and non-alcoholic fatty liver disease, a cross-sectional study
So if you take a high enough dose, there is sedation from it
Incidence of diabetes has shown an increasing trend, the 9 th edition of the Global Diabetes Atlas(Saeedi et al
Whey, casein and plant-based protein powders can supplement diet